Decoy Therapeutics is trading at $3.16, up 8.89%, with no clear company-specific catalyst identified.

  • No clear August 31, 2026, company-specific announcement was identified in available reliable coverage.
  • The latest notable items were an August 3 intellectual-property expansion and August 12 second-quarter results, both stale catalysts for this pre-market move.
  • Broader markets were mixed, with futures slightly weaker overall, leaving the gain’s catalyst unclear.